MDK and brain neoplasm: The oncogenic role of MDK, promoting proliferation and pharmacological resistance in glioma, may involve the release of Sonic Hedgehog (SHH) from LRP2 sequestration in oligodendrocytes [75], thus functioning to activate one of the best-known activators of proliferation and stemness of brain tumors [76].